Madrigal Pharmaceuticals (MDGL) EPS (Basic) (2010 - 2026)
Madrigal Pharmaceuticals (MDGL) posted quarterly EPS (Basic) of -$1.96 for Q2 2026, down 2.99% year-over-year from -$2.02 in Q2 2025, and up 38.33% quarter-over-quarter from -$3.18 in Q1 2026.
Madrigal Pharmaceuticals (MDGL) EPS (Basic) (2010 - 2026) Analysis & Trends
Madrigal Pharmaceuticals (MDGL) has reported EPS (Basic) for 17 consecutive years, with -$1.96 the latest figure, recorded in Q2 2026.
- In Q2 2026, EPS (Basic) fell 2.99% year-over-year to -$1.96; the TTM figure through Jun 2026 stood at -$14.84 (down 22.82% YoY), while the FY2025 annual figure was -$38.06, up 15.67% from the prior year.
- EPS (Basic) grew to -$1.96 in Q2 2026 per MDGL's latest filing, from -$3.18 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$1.9 in Q2 2025 and bottomed at -$7.67 in Q4 2025.
- Historically, EPS (Basic) has averaged -$4.56 across 5 years, with a median of -$4.72 in 2022.
- On a YoY basis, EPS (Basic) climbed as much as 73.19% in 2025 and fell as far as 255.71% in 2025.
- Madrigal Pharmaceuticals' EPS (Basic) stood at -$5.01 in 2022, then fell by 19.77% to -$6.0 in 2023, then soared by 64.1% to -$2.16 in 2024, then slumped by 255.71% to -$7.67 in 2025, then soared by 74.42% to -$1.96 in 2026.
- Business Quant data shows MDGL's EPS (Basic) at -$1.96 in Q2 2026, -$3.18 in Q1 2026, and -$7.67 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 7.59 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.06 |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 0.16 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 0.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 0.18 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.23 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -0.06 |
| 10 | Madrigal Pharmaceuticals | 14.79 Bn | 13.95 Bn | - | -1.96 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.96 |
| Mar 31, 2026 | -3.18 |
| Dec 31, 2025 | -7.67 |
| Sep 30, 2025 | -4.94 |
| Jun 30, 2025 | -1.90 |
| Mar 31, 2025 | -3.32 |
| Dec 31, 2024 | -2.79 |
| Sep 30, 2024 | -4.92 |
| Jun 30, 2024 | -7.10 |
| Mar 31, 2024 | -7.38 |
| Dec 31, 2023 | -6.00 |
| Sep 30, 2023 | -5.34 |
| Jun 30, 2023 | -4.69 |
| Mar 31, 2023 | -4.23 |
| Dec 31, 2022 | -5.01 |
| Sep 30, 2022 | -4.75 |
| Jun 30, 2022 | -4.14 |
| Mar 31, 2022 | -3.36 |
| Dec 31, 2021 | -3.90 |
| Sep 30, 2021 | -3.79 |